Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 333 followers

Latest posts

Last updated about 4 hours ago

Human medicines European public assessment report (EPAR): Calquence, acalabrutinib, Date of authorisation: 05/11/2020, Revision: 12, Status: Authorised

about 4 hours ago

Human medicines European public assessment report (EPAR): Calquence, acalabrutinib, Date of authorisation...

Human medicines European public assessment report (EPAR): Altuvoct, efanesoctocog alfa, Date of authorisation: 17/06/2024, Revision: 3, Status: Authorised

about 4 hours ago

Human medicines European public assessment report (EPAR): Altuvoct, efanesoctocog alfa, Date of...

Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation: 27/06/2006, Revision: 53, Status: Authorised

about 5 hours ago

Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation...

Agenda of the PRAC meeting 6-9 July 2026

about 5 hours ago

Agenda of the PRAC meeting 6-9 July 2026

Agenda of the HMPC meeting 6-8 July 2026

about 5 hours ago

Agenda of the HMPC meeting 6-8 July 2026

Human medicines European public assessment report (EPAR): Enhertu, trastuzumab deruxtecan, Date of authorisation: 18/01/2021, Revision: 20, Status: Authorised

about 5 hours ago

Human medicines European public assessment report (EPAR): Enhertu, trastuzumab deruxtecan, Date of...

Start of procedure: Extension of marketing authorisation (22 May 2026 - 25 June 2026)

about 7 hours ago

Start of procedure: Extension of marketing authorisation (22 May 2026 - 25...

Start of procedure: Type II Variation - Extension of indication under evaluation by the CHMP (22 May 2026 - 25 June 2026)

about 7 hours ago

Start of procedure: Type II Variation - Extension of indication under evaluation...

Human medicines European public assessment report (EPAR): Alprolix, eftrenonacog alfa, Date of authorisation: 12/05/2016, Revision: 12, Status: Authorised

about 8 hours ago

Human medicines European public assessment report (EPAR): Alprolix, eftrenonacog alfa, Date of...

17th Industry Standing Group (ISG) meeting, Online, from 29 June 2026, 09:30 (CEST) to 29 June 2026, 13:10 (CEST)

about 11 hours ago

17th Industry Standing Group (ISG) meeting, Online, from 29 June 2026, 09:30...

PRAC recommendations on signals adopted at the 8-11 June 2026 PRAC meeting

about 12 hours ago

PRAC recommendations on signals adopted at the 8-11 June 2026 PRAC meeting